Even the the damn twitter card for this Nature Scientific Reports is clearly AI Slop.
Posts by Afaf Osman
Love our brilliant genetic counselors
learning about Hepcidin from the legendary Dr. Ganz at our yearly Wintrobe lecture.
learning about Hepcidin from the legendary Dr. Ganz at our yearly Wintrobe lecture.
Dietary saturated fatty acids promote lung myeloid cell inflammasome activation and IL-1β–mediated inflammation in mice and humans
www.science.org/doi/10.1126/...
The revised AML relapse model includes 9 predictors, grouped into 3 risk categories that are each associated with distinct OS. buff.ly/woUnuRm #hemesky
A reminder that tens of millions of people are being exposed to dangerous levels of wildfire smoke again this summer.
Wildfire smoke can be up to 10 times more harmful to people than other sources of smog
#wildfire
leahy.substack.com/p/wildfire-s...
🧠💉 Curious about how aging affects your blood?
Join Dr. Anna Parks for a fascinating talk on aging and blood clots—what you need to know, what science is discovering, and how it could impact your health.
hemostasistoday.com/insight/nbca...
The "iconic and magical" cottonwood trees are the keystone species of the plant world and they're disappearing from Utah riverbanks. Scientists are trying to protect thembut budget freezes by President Trump jeopardizes the work.
At some point, someone invested in us.
Now it’s our turn.
Join me in supporting the #Fight4Hematology and help secure the future of hematology research and care!
Support the
@ASH_hematology
foundation hematology.org/foundation
Proud to share our paper describing two large Li Fraumeni cohorts with a wide variety of hematologic malignancies, some with surprisingly good outcomes:
Hematologic Malignancy Frequency, Phenotypes, and Outcomes in Li-Fraumeni Syndrome | JCO Precision Oncology ascopubs.org/doi/full/10....
Thinking of the millions who have to withstand this heat with no electricity or air conditioning ..
Heartbreaking but he did get to meet his daughter RIP
Practice-changing RCT at #ISTH2025 Late-Breaking Clinical Trial!!!
In acute VTE patients, apixaban therapy led to less clinically-relevant bleeding than rivaroxaban for the first 3 months of therapy. Kudos to Dr Castellucci and colleagues. #COBRRA-VTE
Can’t say I didn’t expect #VERONA to be negative but still disappointing. Just had to do a hospice conversation with a patient with high risk #MDS. We desperately need new therapies for this disease.
The BEST way to go back to work after maternity leave: the inaugural Western Blood Conference at the beautiful Sundance #wbc2025 @ramgar29b.bsky.social @huntsmancancer.bsky.social
Very excited to share that that the Myelomatch study I am leading is open to accrual! We are investigating ASTX727 +/- enasidenib in higher-risk IDH2m MDS
clinicaltrials.gov/study/NCT065...
Great news
Mike spotted this before the rest of us. 🫡
Publications from 2025 are shared more on Bluesky than on X/Twitter.
I’m not surprised
Research-driven advances in cancer science have led to new treatments for the thousands of people diagnosed with rare cancers. Learn more on #RareDiseaseDay: cancerprogressreport.aacr.org/progress/cpr.... #CancerResearchSavesLives® #FundNIH
Actually, not so rare at all!
#RareDiseaseDay
Affecting a substantial part of human kind!
Support research on rare diseases!
Picture from rarediseaseday.org
In 2025, about 1 in 5 cancers diagnosed in the U.S. will be considered rare. Though uncommon individually, rare cancers impact over 400,000 people each year. This weekend, the Beacon of Hope shines in zebra stripes to honor Rare Disease Day and those affected by rare cancers.
Today is #rare disease day. Many of the cancers we treat are rare diseases. #NIH and #NCI funding is critical to support research on rare diseases specifically.
James Webb Satellite took a fantastic shot of the Planet Saturn with it's Near Infrared Camera (NIRCam) and the Mid-Infrared Instrument (MIRI). This is just an Amazing shot that shows the planet and the rings in brilliant detail.
Well deserved!!
Thank you AACR for advocating for cancer research at such a critical time.